DE19675019I2 - Substituierte verbrückte Diabicycloalkylchinoloncarbonsäure. - Google Patents

Substituierte verbrückte Diabicycloalkylchinoloncarbonsäure.

Info

Publication number
DE19675019I2
DE19675019I2 DE1996175019 DE19675019C DE19675019I2 DE 19675019 I2 DE19675019 I2 DE 19675019I2 DE 1996175019 DE1996175019 DE 1996175019 DE 19675019 C DE19675019 C DE 19675019C DE 19675019 I2 DE19675019 I2 DE 19675019I2
Authority
DE
Germany
Prior art keywords
diabicycloalkylquinolonecarboxylic
acid
substituted bridged
alkyl
carbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE1996175019
Other languages
German (de)
English (en)
Inventor
Martin Raymond Jefson
Paul Robert Mcguirk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of DE19675019I2 publication Critical patent/DE19675019I2/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Materials For Photolithography (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE1996175019 1985-09-18 1986-09-12 Substituierte verbrückte Diabicycloalkylchinoloncarbonsäure. Active DE19675019I2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77747185A 1985-09-18 1985-09-18

Publications (1)

Publication Number Publication Date
DE19675019I2 true DE19675019I2 (de) 2004-01-29

Family

ID=25110350

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1996175019 Active DE19675019I2 (de) 1985-09-18 1986-09-12 Substituierte verbrückte Diabicycloalkylchinoloncarbonsäure.
DE8686307045T Expired - Lifetime DE3683711D1 (de) 1985-09-18 1986-09-12 Substituierte verbrueckte diabicycloalkylchinoloncarbonsaeure.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8686307045T Expired - Lifetime DE3683711D1 (de) 1985-09-18 1986-09-12 Substituierte verbrueckte diabicycloalkylchinoloncarbonsaeure.

Country Status (42)

Country Link
US (3) US4775668A (enEXAMPLES)
EP (1) EP0215650B1 (enEXAMPLES)
JP (1) JPH0798819B2 (enEXAMPLES)
KR (1) KR870000961B1 (enEXAMPLES)
CN (1) CN1014789B (enEXAMPLES)
AT (1) ATE72245T1 (enEXAMPLES)
AU (1) AU576302B2 (enEXAMPLES)
BG (2) BG49275A3 (enEXAMPLES)
CA (1) CA1340734C (enEXAMPLES)
CY (1) CY1774A (enEXAMPLES)
CZ (1) CZ277825B6 (enEXAMPLES)
DD (1) DD259190A5 (enEXAMPLES)
DE (2) DE19675019I2 (enEXAMPLES)
DK (1) DK171276B1 (enEXAMPLES)
EG (1) EG18184A (enEXAMPLES)
ES (1) ES2001428A6 (enEXAMPLES)
FI (1) FI87565C (enEXAMPLES)
GR (1) GR862363B (enEXAMPLES)
HK (1) HK132795A (enEXAMPLES)
HU (1) HU200462B (enEXAMPLES)
IE (1) IE58966B1 (enEXAMPLES)
IL (1) IL80033A (enEXAMPLES)
IN (1) IN166416B (enEXAMPLES)
LU (1) LU90356I2 (enEXAMPLES)
MA (1) MA20770A1 (enEXAMPLES)
MW (1) MW5886A1 (enEXAMPLES)
MX (1) MX173358B (enEXAMPLES)
MY (1) MY102518A (enEXAMPLES)
NO (1) NO170335C (enEXAMPLES)
NZ (1) NZ217614A (enEXAMPLES)
OA (1) OA08410A (enEXAMPLES)
PH (2) PH24048A (enEXAMPLES)
PL (1) PL149987B1 (enEXAMPLES)
PT (1) PT83388B (enEXAMPLES)
SG (1) SG28094G (enEXAMPLES)
SK (1) SK667886A3 (enEXAMPLES)
SU (1) SU1482531A3 (enEXAMPLES)
UA (1) UA6340A1 (enEXAMPLES)
YU (1) YU45024B (enEXAMPLES)
ZA (1) ZA867063B (enEXAMPLES)
ZM (1) ZM8586A1 (enEXAMPLES)
ZW (1) ZW19386A1 (enEXAMPLES)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166416B (enEXAMPLES) * 1985-09-18 1990-05-05 Pfizer
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
ATE58538T1 (de) * 1986-07-04 1990-12-15 Chemie Linz Gmbh 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
US4965273A (en) * 1986-10-08 1990-10-23 Bristol-Myers Company Certain 1-tertiary-butyl-naphthyridone carboxylic acid derivatives anti-bacterial agents
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
US4968799A (en) * 1987-07-31 1990-11-06 Warner-Lambert Company Antibacterial agents
US4923879A (en) * 1987-07-31 1990-05-08 Warner-Lambert Company 1,8-Naphthyridines and their use as antibacterial agents
US4992546A (en) * 1987-07-31 1991-02-12 Warner-Lambert Company Process for preparing 6,8-diazabicyclo[3.2.2]nonane derivatives
US4933335A (en) * 1987-08-07 1990-06-12 Warner-Lambert Company Quinolones as antibacterial agents
WO1989005643A1 (en) * 1987-12-18 1989-06-29 Pfizer Inc. Heterocyclic-substituted quinoline-carboxylic acids
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
US5147873A (en) * 1988-08-23 1992-09-15 Pfizer Inc. Amino-substituted bridged azabicyclic quinolone carboxylic acids and esters
WO1990002123A1 (en) * 1988-08-23 1990-03-08 Pfizer Inc. Amino-substituted bridged azabicyclic quinolone carboxylic acids and esters
US4895943A (en) * 1988-10-25 1990-01-23 Pfizer Inc. Preparation of 1,4-diazabicyclo(3.2.2)nonane
US5036153A (en) * 1989-05-11 1991-07-30 Braish Tamim F Preparation of 2,5-diazabicyclo[2.2.1]heptanes and intermediates
US5214051A (en) * 1989-08-01 1993-05-25 Pfizer Inc. Thiazolyl and oxazolyl[5,4-c]piperidyl-substituted quinolone-carboxylic acid and related analogs thereof having antibacterial properties are disclosed
US5095121A (en) * 1989-09-25 1992-03-10 Pfizer Inc Process for optically active 2-alkyl-2,5-diazabicyclo(2.2.1)heptanes
US5157125A (en) * 1989-09-25 1992-10-20 Pfizer Inc. Optically active 2-alkyl-2,5-diazabicyclo[2.2.1]heptanes
US5013839A (en) * 1989-09-25 1991-05-07 Pfizer Inc. Process for optically active 2-alkyl-2,5-diazabicyclo(2.2.1) heptanes
US5385913A (en) * 1989-10-06 1995-01-31 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
WO1991004972A1 (en) * 1989-10-06 1991-04-18 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
US4992449A (en) * 1990-02-01 1991-02-12 American Cyanamid Company 7-(substituted)cycloalkylamino-1-(substituted)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
US5580872A (en) * 1990-05-02 1996-12-03 Abbott Laboratories Quinolizinone type compounds
JPH082901B2 (ja) * 1991-03-01 1996-01-17 ファイザー・インコーポレーテッド １−アザビシクロ［３．２．２ノナン−３−アミン誘導体類
US5235054A (en) * 1992-07-15 1993-08-10 Pfizer Inc. 3-carboxaldehyde substituted quinolines and naphthyridines
GB2291421A (en) * 1994-07-16 1996-01-24 Pfizer A process for preparing a quinoline carboxylic acid
ES2092963B1 (es) * 1995-04-12 1997-12-16 Sint Quimica Sa Procedimiento para la preparacion del acido 1-ciclopropil-6-fluoro-1, 4-dihidro-7-(1s,4s)-5-metil-2,5-diazabiciclo(2.2.1) hept-2-il)-4-oxo-3-quinolincarboxilico y sus sales.
US5929086A (en) * 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
US6056436A (en) * 1997-02-20 2000-05-02 University Of Maryland Simultaneous measurement of temperature and strain using optical sensors
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
NZ513575A (en) 1999-05-04 2003-07-25 Neurosearch As Heteroaryl diazabicycloalkanes useful for treating or preventing a disease or a disorder responsive to the activity of nAChR modulators
FR2809732B1 (fr) * 2000-05-31 2002-07-19 Sanofi Synthelabo DERIVES DE 4(-2-PHENYLTHIAZOL-5-yl)-1,4-DIAZABICYCLO-[3.2.2] NONANE, LEUR PREPARATION ET LEUR APPLICATION ENTHERAPEUTIQUE
FR2809731B1 (fr) * 2000-05-31 2002-07-19 Sanofi Synthelabo Derives de 1,4-diazabicyclo-[3.2.2] nonane-pheylisoxazole, leur preparation et leur application en therapeutique
FR2809730B1 (fr) * 2000-05-31 2002-07-19 Sanofi Synthelabo Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
US7329754B2 (en) * 2001-03-02 2008-02-12 Neurosearch A/S 2,5-diazabicyclo[2.2.1]heptane derivatives
CA2498291C (en) * 2002-09-10 2009-04-07 Pfizer Products Inc. Diazabicyclic compounds useful in the treatment of cns and other disorders
AU2003276919B2 (en) * 2002-09-25 2013-05-16 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
RS20060391A (en) * 2003-12-22 2008-11-28 Memory Pharmaceuticals Corporation, Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2- benzisothiazoles, and preparation and uses thereof
CA2560741C (en) 2004-03-25 2013-08-06 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
EP1742944B1 (en) * 2004-04-22 2010-11-10 Memory Pharmaceuticals Corporation Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
ATE505470T1 (de) * 2004-05-07 2011-04-15 Memory Pharm Corp 1h-indazole, benzothiazole, 1,2-benzisoxazole, 1, 2-benzisothiazole und chromone und deren herstellung und verwendungen
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
WO2006069097A2 (en) 2004-12-22 2006-06-29 Memory Pharmaceuticals Corporation Nicotinic alpha-7 receptor ligands and preparation and uses thereof
US8106066B2 (en) 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
JP2009526024A (ja) 2006-02-10 2009-07-16 ノイロサーチ アクティーゼルスカブ ニコチン性アセチルコリン受容体アゴニストとしての３−ヘテロアリール−３，９−ジアザビシクロ［３．３．１］ノナン誘導体
JP2009526023A (ja) 2006-02-10 2009-07-16 ノイロサーチ アクティーゼルスカブ ３，９−ジアザビシクロ［３．３．１］ノナン誘導体及びモノアミン神経伝達物質再取り込み阻害薬としてのその使用
AU2007213669A1 (en) 2006-02-10 2007-08-16 Neurosearch A/S 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
WO2009111680A1 (en) * 2008-03-07 2009-09-11 Smithline Beecham Corporation Trpv4 antagonists
AU2010221990B2 (en) * 2009-03-11 2015-06-04 Kyorin Pharmaceutical Co., Ltd. 7-cycloalkylaminoquinolones as GSK-3 inhibitors
EP2627314B1 (en) 2010-10-12 2020-05-06 Bayer Intellectual Property GmbH Non-starch based soft chewables
UA118748C2 (uk) 2012-12-19 2019-03-11 Байєр Енімал Хелс Гмбх Таблетки, що мають покращене сприйняття та хорошу стабільність при зберіганні
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor
CN114727622A (zh) * 2019-09-06 2022-07-08 礼蓝美国公司 适口颗粒状兽用药组合物
CN115368369A (zh) * 2022-08-16 2022-11-22 浙江国邦药业有限公司 一种甲磺酸达氟沙星脱甲基杂质的合成方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
US4292317A (en) * 1977-09-20 1981-09-29 Laboratorie Roger Bellon 1,4-Dihydro-quinoline-3-carboxylic acid derivatives, process for their preparation and compositions containing them
JPS54112876A (en) * 1978-02-20 1979-09-04 Sumitomo Chem Co Ltd Preparation of 1-substituted-1,4-dihydro-4-oxo-3-quinoline carboxylic acid derivatives
JPS5845426B2 (ja) * 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
JPS5823382A (ja) * 1981-08-05 1983-02-12 Nec Corp コンテイギユアス・デイスク・バブル検出・消去器
JPS5823381A (ja) * 1981-08-05 1983-02-12 Nec Corp 磁気バブル検出装置
JPS58204193A (ja) * 1982-01-14 1983-11-28 Kobe Steel Ltd 表面処理鋼板
US4499091A (en) * 1982-03-31 1985-02-12 Sterling Drug Inc. 1-Amino (or substituted amino)-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents
EP0090424B1 (en) * 1982-03-31 1986-05-28 Sterling Drug Inc. New quinolone compounds and preparation thereof
JPS58204194A (ja) * 1982-05-21 1983-11-28 Hitachi Ltd 電気ニツケルメツキ方法
JPS58219293A (ja) * 1982-06-15 1983-12-20 Chiyoda Chem Eng & Constr Co Ltd 重質油の水素化分解方法
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
JPS59137481A (ja) * 1983-01-26 1984-08-07 Hokuriku Seiyaku Co Ltd ７−ジアザビシクロアルカン置換−４−オキソ−１，４−ジヒドロキノリン−３−カルボン酸誘導体
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
DE3576335D1 (de) * 1984-12-14 1990-04-12 Daiichi Seiyaku Co Chinolincarbonsaeure-derivate.
IL77846A (en) * 1985-03-25 1989-08-15 Warner Lambert Co Process for the preparation of 7-amino-quinolin-4-oxy-3-carboxylic acid derivatives
US4578473A (en) * 1985-04-15 1986-03-25 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
US4684648A (en) * 1985-05-10 1987-08-04 Otsuka Pharmaceutical Company Limited Antimicrobial 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds and compositions thereof
IN166416B (enEXAMPLES) * 1985-09-18 1990-05-05 Pfizer
US4772706A (en) * 1986-01-13 1988-09-20 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
US4840956A (en) * 1986-02-18 1989-06-20 Warner-Lambert Company Novel disubstituted-7-pyrrolidinoquinoline antibacterial agents
DE3721745A1 (de) * 1986-07-04 1988-01-14 Lentia Gmbh Bicyclisch substituierte chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
ATE58538T1 (de) * 1986-07-04 1990-12-15 Chemie Linz Gmbh 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE3641312A1 (de) * 1986-12-03 1988-06-09 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
US4923879A (en) * 1987-07-31 1990-05-08 Warner-Lambert Company 1,8-Naphthyridines and their use as antibacterial agents
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent

Also Published As

Publication number Publication date
IN166416B (enEXAMPLES) 1990-05-05
HU200462B (en) 1990-06-28
YU45024B (en) 1991-06-30
PH25338A (en) 1991-04-30
MA20770A1 (fr) 1987-04-01
PT83388A (en) 1986-10-01
UA6340A1 (uk) 1994-12-29
FI87565C (fi) 1993-01-25
CZ277825B6 (en) 1993-06-16
US4861779A (en) 1989-08-29
EG18184A (en) 1992-12-30
SK278605B6 (en) 1997-11-05
EP0215650A2 (en) 1987-03-25
IL80033A (en) 1992-05-25
IE58966B1 (en) 1993-12-01
KR870003106A (ko) 1987-04-15
DK445886D0 (da) 1986-09-17
GR862363B (en) 1987-01-19
FI87565B (fi) 1992-10-15
ZA867063B (en) 1988-04-27
ES2001428A6 (es) 1988-05-16
MW5886A1 (en) 1987-12-09
IE862479L (en) 1987-03-18
MY102518A (en) 1992-07-31
DD259190A5 (de) 1988-08-17
EP0215650B1 (en) 1992-01-29
AU6276886A (en) 1987-03-19
CA1340734C (en) 1999-09-14
BG61091B2 (bg) 1996-10-31
PL149987B1 (en) 1990-04-30
FI863756A0 (fi) 1986-09-17
OA08410A (fr) 1988-06-30
KR870000961B1 (ko) 1987-05-14
ATE72245T1 (de) 1992-02-15
CN86106385A (zh) 1987-06-03
PH24048A (en) 1990-03-05
ZM8586A1 (en) 1987-03-27
CZ667886A3 (en) 1993-02-17
JPS62103083A (ja) 1987-05-13
SG28094G (en) 1994-10-28
EP0215650A3 (en) 1987-12-02
FI863756L (fi) 1987-03-19
JPH0798819B2 (ja) 1995-10-25
US4775668A (en) 1988-10-04
YU161786A (en) 1987-10-31
MX3751A (es) 1993-09-01
LU90356I2 (fr) 1999-04-26
SK667886A3 (en) 1997-11-05
NO170335C (no) 1992-10-07
HK132795A (en) 1995-09-01
CN1014789B (zh) 1991-11-20
AU576302B2 (en) 1988-08-18
NO863718L (no) 1987-03-19
DK445886A (da) 1987-05-27
NO170335B (no) 1992-06-29
CY1774A (en) 1995-10-20
PT83388B (pt) 1989-05-12
SU1482531A3 (ru) 1989-05-23
MX173358B (es) 1994-02-23
PL261410A1 (en) 1987-11-16
DK171276B1 (da) 1996-08-19
HUT43070A (en) 1987-09-28
ZW19386A1 (en) 1986-12-10
NO863718D0 (no) 1986-09-17
BG49275A3 (en) 1991-09-16
NZ217614A (en) 1989-11-28
DE3683711D1 (de) 1992-03-12
US5091383A (en) 1992-02-25
IL80033A0 (en) 1986-12-31

Similar Documents

Publication Publication Date Title
DE19675019I2 (de) Substituierte verbrückte Diabicycloalkylchinoloncarbonsäure.
FI914928A0 (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
ATE68473T1 (de) 1-phenyl-3-naphthalenyloxy-propanamine.
DE3572170D1 (de) Quinolonecarboxylic acid derivatives
ATE83377T1 (de) Antianaerobe naphthyridinverbindungen.
ATE84028T1 (de) Biologisch aktive verbindungen.
ES2093051T3 (es) Purinil- y pirimidil-tetrahidrofuranos.